Is it Feasible to Use the Commercially Available Autoquantitation Software for the Evaluation of Myocardial Viability on Small-Animal Cardiac F-18 FDG PET Scan?

  • Pahk, K.; 
  • Oh, S.Y.; 
  • Jeong, E.; 
  • Lee, S.H.; 
  • Woo, S.K.; 
  • 외 3명
Citations

SCOPUS

2

초록

Purpose: To evaluate the reliability of quantitation of myocardial viability on cardiac F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) scans with three different methods of visual scoring system, autoquantitation using commercially available autoquantitation software, and infarct-size measurement using histogram-based maximum pixel threshold identification on polar-map in rat hearts. Methods: A myocardial infarct (MI) model was made by left anterior descending artery (LAD) ligation in rat hearts. Eighteen MI rats underwent cardiac FDG-PET-computed tomography (CT) twice within a 4-week interval. Myocardium was partitioned into 20 segments for the comparison, and then we quantitated non-viable myocardium on cardiac FDG PET-CT with three different methods: method A-infarct-size measurement using histogram-based maximum pixel threshold identification on polar-map; method B-summed MI score (SMS) by a four-point visual scoring system; method C-metabolic non-viable values by commercially available autoquantitation software. Changes of non-viable myocardium on serial PET-CT scans with three different methods were calculated by the change of each parameter. Correlation and reproducibility were evaluated between the different methods. Results: Infarct-size measurement, visual SMS, and non-viable values by autoquantitation software presented proportional relationship to each other. All the parameters of methods A, B, and C showed relatively good correlation between each other. Among them, infarct-size measurement (method A) and autoquantitation software (method C) showed the best correlation (r = 0.87, p < 0.001). When we evaluated the changes of non-viable myocardium on the serial FDG-PET-CT- however, autoquantitation program showed less correlation with the other methods. Visual assessment (method B) and those of infarct size (method A) showed the best correlation (r = 0.54, p = 0.02) for the assessment of interval changes. Conclusions: Commercially available quantitation software could be applied to measure the myocardial viability on small animal cardiac FDG-PET-CT scan. This kind of quantitation showed good correlation with infarct size measurement by histogram-based maximum pixel threshold identification. However, this method showed the weak correlation when applied in the measuring the changes of non-viable myocardium on the serial scans, which means that the caution will be needed to evaluate the changes on the serial monitoring. © 2013 Korean Society of Nuclear Medicine.

키워드

Autoquantitation; FDG PET; Myocardial infarct model; Myocardial viability; fluorodeoxyglucose f 18; animal experiment; animal model; animal tissue; article; computer program; controlled study; correlation coefficient; feasibility study; heart infarction; heart infarction size; heart muscle; image analysis; image processing; left anterior descending coronary artery; limit of quantitation; male; nonhuman; PET scanner; positron emission tomography; priority journal; rat; reliability; reproducibility; scoring system
제목
Is it Feasible to Use the Commercially Available Autoquantitation Software for the Evaluation of Myocardial Viability on Small-Animal Cardiac F-18 FDG PET Scan?
저자
Pahk, K.; Oh, S.Y.; Jeong, E.; Lee, S.H.; Woo, S.K.; Yu, J.W.; Choe, J.G.; Cheon, G.J.
DOI
10.1007/s13139-013-0206-8
발행일
2013
유형
Article
저널명
Nuclear Medicine and Molecular Imaging
권
47
호
2
페이지
104 ~ 114